Drug Designing and Biomarkers

Drug designing is an inventive process of finding new medication based on the target knowledge. A drug is commonly a small compound which produces a therapeutic effect. There are different methods of drug designing. Designing a drug based on the three-dimensional structure and computational techniques are known as structure-based drug design and computer aided drug design respectively. There are various stages involved in computer aided drug design such as hit identification, hit to lead optimization and lead optimization. In structure-based drug design, the structure is obtained either through x-ray crystallography or NMR spectroscopy. Ligand-based drug design depends on the knowledge of molecules that bind to the biological target of our interest. Correlation between calculated and theoretical can be derived and this QSAR relationship is used to derive analogs. Biomarkers include tools and technologies that aid in dynamic and powerful approach to understand the spectrum of neurological diseases in knowing the prediction, cause, diagnosis, progression, regression, or outcome of treatment of a disease

    Related Conference of Drug Designing and Biomarkers

    January 19-20, 2026

    17th International Conference on Biofuels and Bioenergy

    Barcelona, Spain
    May 04-05, 2026

    7th International Conference on Drug Chemistry

    Paris, France
    July 23-24, 2026

    22nd World Congress on Structural Biology

    Aix-en-Provence, France
    September 03-04, 2026

    16th World Glycobiology Congress

    Aix-en-Provence, France
    September 21-22, 2026

    24th International Conference on Structural Biology

    Barcelona, Spain

    Drug Designing and Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in